Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lauri Burroughs, MD
Fred Hutch/University of Washington Cancer Consortium
Study Chair - Margaret MacMillan, MD
University of Minnesota
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Rady Children'S Hospital/ucsd
San Diego, California, United States
- University of California San Francisco
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Boston Children'S Hospital
Boston, Massachusetts, United States
- University of Michigan Medical Center
Ann Arbor, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- St. Louis Children'S Hospital
St Louis, Missouri, United States
- Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Cohen Children'S Hospital of Ny
Queens, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Texas Children'S Hospital
Houston, Texas, United States
- Primary Children'S/university of Utah
Salt Lake City, Utah, United States
- Fred Hutch/university of Washington Cancer Consortium
Seattle, Washington, United States
- Medical College of Wisconsin/children'S Hospital of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Apr 2022
- Primary completion
- 18 Feb 2026
- Completion
- 18 Feb 2026
- Last update posted
- 9 Mar 2026
- Registered enrollment
- 40
- Registry id
- NCT04965597
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.